ELZA at KCXL2025 – Thin Cornea CXL
Prof. Farhad Hafezi presented five-year outcomes and future directions of the sub400 protocol for thin cornea CXL at the KCXL Experts’ Meeting 2025 in Milan.
Mark Hillen
December 19, 2025
Prof. Farhad Hafezi presented five-year outcomes and future directions of the sub400 protocol for thin cornea CXL at the KCXL Experts’ Meeting 2025 in Milan.
Emilio Torres-Netto reviewed the evolution of epi-on CXL at KCXL 2025, explaining early failures and how modern protocols now achieve clinically meaningful keratoconus stabilisation.
Prof. Hafezi presented new insights on PACK-CXL, ELZA-PACE, and epi-on CXL at EPOMEC 2025, shaping future keratoconus management.
Keratoconus affects not only the cornea but also the retina, choroid, and optic nerve head, as shown in a meta-analysis co-authored by Prof. Farhad Hafezi.
ELZA joined the SCHWIND User Meeting 2025 in Bangkok to share our insights on advanced laser eye surgery.
ELZA Institute’s Dr. Torres-Netto presents advances in surgical keratoconus treatment and ELZA-PACE-CXL at AAO 2025.
Nikki Hafezi expands K-MAP to Andijan, Uzbekistan, expanding keratoconus screening to the Fergana Valley.
Bulging eyes from thyroid disease can be treated at ELZA by Dr. Dion Paridaens, a pioneer of the transconjunctival (swinging-eyelid) surgical approach.
Auf dem ESCRS 2025 in Kopenhagen präsentierte Dr. Emilio A. Torres-Netto neue Strategien zur Behandlung von Patienten mit Katarakt und Keratokonus – einer besonders anspruchsvollen Kombination.
Prof. Hafezi was interviewed by Ocular Surgery News on his co-authorship of the II Global Consensus on Keratoconus – a landmark publication that will guide KC treatment for years to come.
